PCSA Processa Pharmaceuticals
- 1.7600
- -0.0400-2.22%
- 1.7600
- 0.00000.00%
Processa Pharmaceuticals News
Express News | Processa Pharmaceuticals - Entered Into Sales Agreement Relating to Sale of Shares of Common Stock Offered by Prospectus Supplement
Express News | Processa Pharmaceuticals Inc - May Offer and Sell Shares of Common Stock of up to $2.4 Mln From Time to Time
Processa Pharmaceuticals Files for $50M Mixed Shelf
Processa Pharmaceuticals Files Base Prospectus For Up To $50M In Securities; Covers Up To $2.4M Of Common Stock To Be Issued And Sold Under Sales Agreement With A.G.P./Alliance Global Partners
Processa Pharmaceuticals Files Base Prospectus For Up To $50M In Securities; Covers Up To $2.4M Of Common Stock To Be Issued And Sold Under Sales Agreement With A.G.P./Alliance Global Partners
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $8 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma with a Buy and maintains $8 price target.
Analysts Are Bullish on Top Healthcare Stocks: Processa Pharmaceuticals (PCSA), Oculis Holding (OCS)
Processa Pharmaceuticals | 10-Q: Quarterly report
Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference
HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company focused on developing the next gen
Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research
Brings extensive experience in all phases of oncology drug development HANOVER, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a cli
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
HTZ, CYCC and WORX Among Pre-market Losers
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) rose sharply in today's pre-market trading the company posted upbeat results for its first quarter.Google parent Alphabet said its first-quarter re
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersTevogen Bio Holdings (NASDAQ:TVGN) shares rose 75.3% to $1.49 during Friday's pre-market session. The company's market cap stands at $245.2 million. Cryo-Cell International (AMEX:CCEL) shares i
Top Premarket Decliners
SCWorx (WORX) shares retreated 17% Friday premarket, reversing gains from the previous session. Processa Pharmaceuticals (PCSA) shares fell more than 15%, paring Thursday's rally. Boyd Gaming (BYD) sh
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
Top Midday Gainers
H.C. Wainwright started Processa Pharmaceuticals (PCSA) with a buy rating and an $8 price target. Shares soared 41.4%, as intraday trading volume shot to more than 62.6 million from a daily average of
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling by around 250 points on Thursday.The Dow traded down 1.55% to 37,864.79 while the NASDAQ fell 1.60% to 15,460.95. The
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersProcessa Pharma (NASDAQ:PCSA) shares moved upwards by 31.2% to $2.12 during Thursday's pre-market session. The company's market cap stands at $6.0 million. Cyclacel Pharmaceuticals (NASDAQ:CYCC
Processa Pharmaceuticals Initiated at Buy by HC Wainwright & Co.
Processa Pharmaceuticals Initiated at Buy by HC Wainwright & Co.
Processa Pharma (PCSA.US) was first covered by HC Wainwright & Co. and gave it a buy rating, with a target price of $8.00.
Processa Pharma (PCSA.US) was first covered by HC Wainwright & Co. and gave it a buy rating, with a target price of $8.00.
Analysis
Price Target
No Data
